Iosefamic Acid

Iosefamic Acid

SCHEMBL29648519

CNC(=O)c1c(I)c(NC(=O)CCCCCCCCC(=O)Nc2c(I)c(C(=O)O)c(I)c(C(=O)NC)c2I)c(I)c(C(=O)O)c1I

nearest known ligand 0.55

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.55
MAPK1 P28482 1/20 0.55
LMNA P02545 2/20 0.40
SMN1; SMN2 Q16637 1/20 0.38
HDAC1 Q13547 12/20 0.38
HDAC2 Q92769 10/20 0.38
HDAC8 Q9BY41 9/20 0.38
HDAC6 Q9UBN7 9/20 0.38
HDAC11 Q96DB2 8/20 0.38
HDAC5 Q9UQL6 8/20 0.38
HDAC3 O15379 8/20 0.38
HDAC4 P56524 7/20 0.38
HDAC7 Q8WUI4 7/20 0.38
HDAC9 Q9UKV0 7/20 0.38
HDAC10 Q969S8 7/20 0.38
NCOR2 Q9Y618 2/20 0.36
KDM4E B2RXH2 1/20 0.36
BRD4 O60885 1/20 0.36
NCOR1 O75376 1/20 0.36
NR1I2 O75469 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Iosefamic Acid SCHEMBL29400390 1.00 TSHR (0.55) TSHRMAPK1LMNASMN1; SMN2HDAC1
Iosefamic Acid SCHEMBL38639 1.00 TSHR (0.55) TSHRMAPK1LMNASMN1; SMN2HDAC1
Iocarmic Acid SCHEMBL38580 0.98 TSHR (0.56) TSHRMAPK1LMNASMN1; SMN2HDAC1
SCHEMBL9716687 0.86 TSHR (0.52) TSHRMAPK1LMNASMN1; SMN2HDAC1
SCHEMBL30881052 0.85 LMNA (0.42) TSHRMAPK1LMNASMN1; SMN2KDM4E
SCHEMBL8610051 0.85 LMNA (0.42) TSHRMAPK1LMNASMN1; SMN2
SCHEMBL11632856 0.84 MAPK1 (0.46) TSHRMAPK1SMN1; SMN2ALDH1A1
Iocarmic Acid SCHEMBL29886627 0.83 SMN1; SMN2 (0.65) TSHRMAPK1LMNASMN1; SMN2KDM4E
SCHEMBL3833534 0.82 LMNA (0.40) TSHRMAPK1LMNASMN1; SMN2CYP3A4
SCHEMBL11406813 0.81 LMNA (0.47) TSHRMAPK1LMNASMN1; SMN2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240124889-A1 COMPOSITIONS AND METHODS FOR THE VECTORED AUGMENTATION OF PROTEIN DESTRUCTION, EXPRESSION AND/OR REGULATION VOYAGER THERAPEUTICS, INC. 2024-04-18 US disclosed
US-20220389449-A1 COMPOSITIONS FOR THE TREATMENT OF DISEASE VOYAGER THERAPEUTICS, INC. 2022-12-08 US disclosed
US-11326182-B2 Compositions for the treatment of disease VOYAGER THERAPEUTICS, INC. (US) 2022-05-10 US disclosed